leisure time -WSS

leisure time

author：hotspot 2025-09-30 01:01:31 - browse：7686

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT.

Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return the data to CDC within 36 hours of collecting the samples. The contract is limited to those two pathogens but the company is prepared to analyze more if needed, leaders said.

The contract comes as Verily struggles to turn a profit among various disparate health care offerings, like value-based care analytics for health systems, clinical trial software and even an in-person substance use rehabilitation center in Ohio. Despite several prominent hires and a vast number of projects, the company has yet to forge a sustainable business.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Long Covid research funding gets a major boost from NIH

Wikipedia

WSS

Resistance to opioid

New lawsuit accuses health insurer Cigna of denying claims in bulk

Democrats decry new health bill for going easy on private equity

A new crop of companies is reshaping the health data economy

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

New lawsuit accuses health insurer Cigna of denying claims in bulk

entertainment

leisure time

entertainment

Supreme Court strikes down use of affirmative action

'Investigate these claims': UFO transparency at center of House hearing

Trump demands the U.S. pay no more for drugs than other countries … again

Congress must protect the remaining independent doctors

Wildfire smoke exposes gaps in outdoor worker protections

Resistance to opioid

Moonlake's readout produced a cash windfall. Risks remain

STAT Report: Patient voices and perspectives

United colonoscopy coverage change 'may cost lives,' doctors say

UHS says company favors patients whose insurance pays more

leisure time

Abbott's new heart device gets FDA advisory panel nod

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

AMAs digital advisors table RPM coding reform proposal, again

Here’s what’s in the FDA plan to include pregnant women in clinical trials

UHS says company favors patients whose insurance pays more

Abbott's new heart device gets FDA advisory panel nod

focus

Wikipedia

hotspot

hotspot